Søgning på udtrykket 'influenza' giver 45 resultater
Dokumenter [1]
Sider [2]
Kalender [2]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dokumenter [1]
Version 8 (21.11.22)
Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi & Fagligt Selskab for Hygiejnesygeplejersker
Sider [2]
Tarp, Lone Mygind
National Strategi for Hepatitis C (Sundhedsstyrelsen 2023),
Indvandrermedicin:
Chalotte Stecher (tovholder), Hanne Nødgaard Christensen, Christian Wejse, Jane Agergaard, Morten Sodemann og Marie Nørredam
Influenza:
Jens Lundgren (tovholder), Thomas Benfield, Jan Gerstoft, Isik Johansen, Gitte Kronborg, Henrik Nielsen, Lene Surland Knudsen, Merete Storgaard og Ole Kirk
Influenza,
Inspektorordningen i Sundhedsstyrelsen:
Hanne Arildsen, Th
ogle forskellige kilder til viden.
EBJIS.
European Bone and Joint Infection Society (EBJIS) udbyder flere gratis webinarer om knogleinfektioner.
ebjis.org/e-events/on-demand-webinars.
FluNet.
WHO's overvågning af influenza:.
www.who.int/flunet.
HAIBA.
Healthcare-Associated Infections Database (HAIBA) er et nationalt automatisk overvågningssystem til overvågning af infektioner erhvervet i sundhedssektoren.
www.esundhed.dk/Emner/
Kalender [2]
24. januar 2019, Aarhus Universitetshospital
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Virulence
9.12.2023
Volume 15, Issue 1, December 2024 .
Journal of Infectious Diseases
4.12.2023
AbstractBackgroundThe 2022-2023 United States influenza season had unusually early influenza activity with high hospitalization rates. Vaccine-matched A(H3N2) viruses predominated, with lower levels of A(H1N1)pdm09 activity also observed.MethodsUsing the test-negative design, we evaluated influenza vaccine effectiveness (VE) during the 2022-2023 season against influenza-A-associated emergency department/urgent care (ED/UC) visits and hospitalizations from October 2022-March 2023 among adults (age ≥18 year
PLoS One Infectious Diseases
30.11.2023
by Guillermo Mena, Irma Casas, Cristina Casañ, Mario Auñón, Lurdes Matas, Josep-Maria Mòdol, María Esteve .
Journal of Medical Virology
28.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
Journal of Medical Virology
28.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
Clinical Infectious Diseases
26.11.2023
AbstractBackgroundRespiratory syncytial virus (RSV) and influenza are both typically seasonal diseases, with winter peaks in temperate climates. Coadministration of an RSV vaccine and influenza vaccine could be a benefit, requiring 1 rather than 2 visits to a healthcare provider for individuals receiving both vaccines.MethodsThe primary immunogenicity objective of this phase 3, 1:1 randomized, double-blind, placebo-controlled study in healthy ≥65-year-olds in Australia was to demonstrate noninferiority of
Journal of Infectious Diseases
21.11.2023
AbstractBackgroundPre-existing immunity, including memory B-cells and pre-existing antibodies, can modulate antibody responses to influenza in vivo to antigenically related antigens. We investigated whether pre-existing hemagglutination inhibition (HAI) antibodies targeting the K163 epitope on the hemagglutinin (K163-antibodies) could affect antibody responses following vaccination with A/California/07/2009-like (CA/09) A(H1N1)pdm09 influenza viruses in humans.MethodsPre- and post-vaccination sera collected
Journal of Infectious Diseases
19.11.2023
AbstractPreexisting immunity against influenza viruses has long been known to regulate the magnitude and specificity of vaccine-induced humoral immunity. In this manuscript by Lu et al., the authors highlight how varying levels of preexisting antibodies against a single site on hemagglutinin impact vaccine-induced antibody responses. This commentary discusses the essential findings and implications of the study, emphasizing the importance of understanding how preexisting antibodies suppress the diversificat
Clinical Infectious Diseases
18.11.2023
AbstractBackgroundDuring the 2022–2023 influenza season, the United States experienced the highest influenza-associated pediatric hospitalization rate since 2010–2011. Influenza A/H3N2 infections were predominant.MethodsWe analyzed acute respiratory illness (ARI)-associated emergency department or urgent care (ED/UC) encounters or hospitalizations at three health systems among children and adolescents aged 6 months–17 years who had influenza molecular testing during October 2022–March 2023. We estim
Journal of the American Medical Association
15.11.2023
This study provides survey results from state and territorial public health preparedness directors regarding antiviral shortages during the 2022-2023 respiratory viral season.
Journal of Infectious Diseases
13.11.2023
AbstractBackgroundAnnual influenza vaccination is recommended for older adults but repeated vaccination with standard-dose influenza vaccine has been linked to reduced immunogenicity and effectiveness, especially against A(H3N2) viruses.MethodsCommunity-dwelling Hong Kong adults aged 65-82 years were randomly allocated to receive 2017/18 standard-dose quadrivalent, MF59-adjuvanted trivalent, high-dose trivalent, and recombinant-HA quadrivalent vaccination. Antibody response to unchanged A(H3N2) vaccine anti
Infection
10.11.2023
. Abstract. . Purpose. To determine characteristics associated with inappropriate antibiotic use amongst children hospitalised for influenza. . . . Methods. We performed active surveillance for laboratory-confirmed influenza hospitalizations amongst children ≤ 16 years old at the 12 Canadian Immunization Monitoring Program Active hospitals, from Sept
BMC Infectious Diseases
9.11.2023
Abstract. . Background. Common air pollutants such as ozone (O3), sulfur dioxide (SO2), nitrogen dioxide (NO2), and particulate matter play significant roles as influential factors in influenza-like illness (ILI). However, evidence regarding the impact of O3 on influenza transmissibility in multi-subtropical regions is limited, and our understanding of the effects of O3 on influenza transmissibility in temperate regions remain unknown.
BMC Infectious Diseases
9.11.2023
Abstract. . Background. Common air pollutants such as ozone (O3), sulfur dioxide (SO2), nitrogen dioxide (NO2), and particulate matter play significant roles as influential factors in influenza-like illness (ILI). However, evidence regarding the impact of O3 on influenza transmissibility in multi-subtropical regions is limited, and our understanding of the effects of O3 on influenza transmissibility in temperate regions remain unknown.
Clinical Infectious Diseases
9.11.2023
AbstractBackgroundData are limited about influenza vaccine effectiveness (VE) in the prevention of influenza-related hospitalizations in older adults and those with underlying high-risk comorbidities.MethodsWe conducted a prospective test-negative case-control study at two US hospitals from October 2018–March 2020 among adults ≥50 years of age hospitalized with acute respiratory illnesses (ARIs) and adults ≥18 years admitted with congestive heart failure (CHF) or chronic obstructive pulmonary disease
Journal of Medical Virology
8.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
Journal of Medical Virology
7.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
BMC Infectious Diseases
7.11.2023
Abstract. . Background. Common air pollutants such as ozone (O3), sulfur dioxide (SO2), nitrogen dioxide (NO2), and particulate matter play significant roles as influential factors in influenza-like illness (ILI). However, evidence regarding the impact of O3 on influenza transmissibility in multi-subtropical regions is limited, and our understanding of the effects of O3 on influenza transmissibility in temperate regions remain unknown.
Infection
6.11.2023
. Abstract. . Purpose. To determine characteristics associated with inappropriate antibiotic use amongst children hospitalised for influenza. . . . Methods. We performed active surveillance for laboratory-confirmed influenza hospitalizations amongst children ≤ 16 years old at the 12 Canadian Immunization Monitoring Program Active hospitals, from Sept
Science Advances
4.11.2023
Science Advances, Volume 9, Issue 44, November 2023.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Eurosurveillance latest updates
8.12.2023
. Background. Influenza vaccination for children aged 6 months to 6 years is included in the national vaccination programme in Finland. Although all vaccines in the programme are free of charge, national coverage of influenza vaccination among children under 3 years and 3–6 years during 2020/21 was 43% and 35% respectively, with regional differences. . . Aim. To assess factors underlying parental vaccination intention in order to increase influenza vaccine uptake among children. . . Methods. We cond
Morbidity and Mortality Weekly Report (MMWR)
1.12.2023
This report describes the percentage of adults who received a flu vaccine during the past 12 months.
Morbidity and Mortality Weekly Report (MMWR)
9.11.2023
This report describes declines in influenza vaccination coverage among health care personnel working in hospitals during the COVID-19 pandemic.
Morbidity and Mortality Weekly Report (MMWR)
9.11.2023
This report describes the percentage of health care personnel working in hospitals and nursing homes who received a flu vaccine and the percentage who received a COVID-19 vaccine.
Eurosurveillance latest updates
20.10.2023
We report cases of mammalian infection with highly pathogenic avian influenza (HPAI) virus A(H5N1) clade 2.3.4.4b in Northern Ireland. Two common gulls (Larus canus) and two red fox kits (Vulpes vulpes), were found dead in close vicinity. Comparison of viral whole genome sequences obtained from the animals identified a novel mammalian adaptation, PB2-M535I. Analysis of genetic sequences from other recent mammalian infections shows that this mutation has arisen on at least five occasions in three European co
Eurosurveillance latest updates
13.10.2023
. Background. Two human cases of avian influenza A (H3N8) virus infection were reported in China in 2022. . . Aim. To characterise H3N8 viruses circulating in China in September 2021−May 2022. . . Methods. We sampled poultry and poultry-related environments in 25 Chinese provinces. After isolating H3N8 viruses, whole genome sequences were obtained for molecular and phylogenetic analyses. The specificity of H3N8 viruses towards human or avian receptors was assessed in vitro. Their ability to replic
Morbidity and Mortality Weekly Report (MMWR)
12.10.2023
This report describes the 2022-23 influenza season among children, including seasonal severity, estimated incidence, and characteristics of hospitalized patients.
Morbidity and Mortality Weekly Report (MMWR)
6.10.2023
This report describes the severity of respiratory syncytial virus disease among hospitalized older adults compared to hospitalizations for COVID-19 or influenza.
ECDC COVID-19 updates
3.10.2023
This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.
Eurosurveillance latest updates
29.09.2023
A community cluster of influenza A(H3N2) caused by viruses with an E199G substitution in PA was detected in Nara, Japan, between February and March 2023. The three patients with these mutant viruses had not received antiviral treatment before specimen collection but patients in the same hospital had. The sequences of the mutant viruses were closely related, suggesting clonal spread in Nara. They showed reduced susceptibility to baloxavir in vitro; however, the clinical significance of the PA E199G substitut
Morbidity and Mortality Weekly Report (MMWR)
29.09.2023
This report describes influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant people.
Eurosurveillance latest updates
15.09.2023
. Background. COVID-19 pandemic mitigation measures, including travel restrictions, limited global circulation of influenza viruses. In Australia, travel bans for non-residents and quarantine requirements for returned travellers were eased in November 2021, providing pathways for influenza viruses to be re-introduced. . . Aim. We aimed to describe the epidemiological and virological characteristics of the re-emergence of influenza in Victoria, Australia to inform public health interventions. . . Methods
Morbidity and Mortality Weekly Report (MMWR)
15.09.2023
This report describes how emergency department visits and wastewater surveillance data were used to track influenza and respiratory syncytial virus activity in Wisconsin.
Morbidity and Mortality Weekly Report (MMWR)
9.09.2023
This report describes flu vaccine effectiveness data from five South American countries during the 2023 Southern Hemisphere flu season.
Eurosurveillance latest updates
1.09.2023
In April 2023, an outbreak of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses carrying the T271A mammalian adaptive mutation in the PB2 protein was detected in a backyard poultry farm in Italy. Five domestic dogs and one cat living on the premises had seroconverted in the absence of clinical signs. Virological and serological monitoring of individuals exposed to the virus proved the absence of human transmission, however, asymptomatic influenza A(H5N1) infections in mammalian pets may have
Medscape Infectious Diseases
30.08.2023
The CDC's Tim Uyeki, MD, discusses trends in avian influenza A and variant influenza A viruses, as well as guidance on prevention and treatment. . CDC Expert Commentary
Morbidity and Mortality Weekly Report (MMWR)
24.08.2023
This report describes prevention and control of seasonal influenza with vaccines for the 2023-24 season.
Eurosurveillance latest updates
4.08.2023
. Background. Over a 3-week period in late June/early July 2023, Poland experienced an outbreak caused by highly pathogenic avian influenza (HPAI) A(H5N1) virus in cats. . . Aim. This study aimed to characterise the identified virus and investigate possible sources of infection. . . Methods. We performed next generation sequencing and phylogenetic analysis of detected viruses in cats. . . Results. We sampled 46 cats, and 25 tested positive for avian influenza virus. The identified viruses belong to cl
Eurosurveillance latest updates
4.08.2023
In June 2023, a fatal disease outbreak in cats occurred in Poland. Most cases tested in Poland (29 of 47) were positive for highly pathogenic avian influenza (HPAI) A (H5N1) virus. Genetic analyses revealed clade 2.3.4.4b with point mutations indicative of initial mammalian hosts adaptations. Cat viral sequences were highly similar (n = 21), suggesting a potential common infection source. To investigate possible infection routes, our group tested food samples from affected households. HPAI H5N1 virus
Eurosurveillance latest updates
4.08.2023
Since mid-July 2023, an outbreak caused by highly pathogenic avian influenza A(H5N1) virus clade 2.3.4.4b genotype BB is ongoing among farmed animals in South and Central Ostrobothnia, Finland. Infections in foxes, American minks and raccoon dogs have been confirmed on 20 farms. Genetic analysis suggests introductions from wild birds scavenging for food in farm areas. Investigations point to direct transmission between animals. While no human infections have been detected, control measures are being impleme